Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HELIOS TECHNOLOGIES, INC.HLIO · Entity 4399 | Officer | April 27, 2020 | April 29, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HELIOS TECHNOLOGIES, INC.
Report date April 27, 2020 · Filed April 29, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,418 |
Reported balance
After 2020-04-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-27 · Grant · Acquired 5,418 · Balance 5,418 F1: Each RSU represents the right to receive, following vesting, one share of Common Stock. F2: Unless earlier accelerated or forfeited under the terms of the RSU, 100% of the awards vest and convert into Common Stock twenty four months from the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,579 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,579 F4: Restricted stock units granted to reporting person on 2/28/2020, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,061 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,061 F6: Restricted stock units granted to reporting person on 4/1/2019, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 1,358.56 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,358.56 |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,159 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,159 F3: Performance-based restricted stock units granted to the reporting person on 2/28/2020, unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period ending on the last day of the Company's fiscal year ending December 3 1, 2022. |
| Non-qualified Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.75 · Expires 2030-02-28 | Direct | 2,579 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 2,579 F5: Stock Options granted to reporting person on 2/28/2020; unless earlier forfeited under the terms of the Options, 33-1/3% of the options vest and become exercisable on each of the first three anniversaries of the grant date. |
| Performance-based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,090 |
Reported balance
Holding disclosure · report date 2020-04-27 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 3,090 F7: Performance-based restricted stock units granted to the reporting person on 4/1/2019, unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 150% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period ending on the last day of the Company's fiscal year ending January 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents the right to receive, following vesting, one share of Common Stock.
F2: Unless earlier accelerated or forfeited under the terms of the RSU, 100% of the awards vest and convert into Common Stock twenty four months from the grant date.
F3: Performance-based restricted stock units granted to the reporting person on 2/28/2020, unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period ending on the last day of the Company's fiscal year ending December 3 1, 2022.
F4: Restricted stock units granted to reporting person on 2/28/2020, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date.
F5: Stock Options granted to reporting person on 2/28/2020; unless earlier forfeited under the terms of the Options, 33-1/3% of the options vest and become exercisable on each of the first three anniversaries of the grant date.
F6: Restricted stock units granted to reporting person on 4/1/2019, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date.
F7: Performance-based restricted stock units granted to the reporting person on 4/1/2019, unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 150% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period ending on the last day of the Company's fiscal year ending January 1, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2020 Filed Apr 29, 2020 18:56 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | GrantRestricted Stock Units · Derivative | 5,418 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001777847-20-000002 · primary_doc.xml · derivative · entry 2 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 Underlying: Common Stock · 5,418 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents the right to receive, following vesting, one share of Common Stock. F2 · derivative.exercise_date: Unless earlier accelerated or forfeited under the terms of the RSU, 100% of the awards vest and convert into Common Stock twenty four months from the grant date. F2 · derivative.expiration_date: Unless earlier accelerated or forfeited under the terms of the RSU, 100% of the awards vest and convert into Common Stock twenty four months from the grant date. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 16:31 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | Exercise / conversionRestricted Stock Units · Derivative | 1,030 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001777847-20-000001 · primary_doc.xml · derivative · entry 3 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,061 Underlying: Common Stock · 1,030 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units granted to reporting person on 4/1/2019, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 4/1/2019, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 4/1/2019, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 16:31 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | Tax withholdingCommon Stock | 251 | $34.50 | $8,659.50 |
DisclosureSEC source: 0001777847-20-000001 · primary_doc.xml · nonDerivative · entry 2 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358.56 F2 · shares: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 16:31 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | Exercise / conversionCommon Stock | 1,030 | $34.50 | $35,535.00 |
DisclosureSEC source: 0001777847-20-000001 · primary_doc.xml · nonDerivative · entry 1 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609.56 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares purchased through the Helios Technologies, Inc. Employee Stock Purchase Plan (2.2889 dividend reinvestment shares). Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 20:23 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | GrantNon-qualified Stock Options (right to buy) · Derivative | 2,579 | $0.00 Strike: $39.75 | $0.00 |
DisclosureSEC source: 0001692276-20-000014 · primary_doc.xml · derivative · entry 4 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,579 Underlying: Common Stock · 2,579 shares Expires 2030-02-28 F6 · derivative.exercise_date: Unless earlier forfeited under the terms of the Options, 33-1/3% of the options vest and become exercisable on each of the first three anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 20:23 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | GrantRestricted Stock Units · Derivative | 2,579 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001692276-20-000014 · primary_doc.xml · derivative · entry 3 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,579 Underlying: Common Stock · 2,579 shares Expires not disclosed F4 · derivative.exercise_price: Each RSU represents the right to receive, following vesting, one share of Common Stock. F5 · derivative.exercise_date: Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. F5 · derivative.expiration_date: Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 20:23 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | GrantPerformance-Based Restricted Stock Units · Derivative | 5,159 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001692276-20-000014 · primary_doc.xml · derivative · entry 2 Menon Rajasekhar · CIK 0001777847 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,159 Underlying: Common Stock · 5,159 shares Expires not disclosed F2 · derivative.exercise_price: Each performance-based Restricted Stock Unit (RSU) represents the right to receive, following vesting, up to 200% of one share of Helios Technologies common stock (Common Stock). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the Company's fiscal year ending January 2, 2020 and ending on the last day of the Company's fiscal year ending December 31, 2022. F3 · derivative.exercise_date: Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period beginning on the first day of the Company's fiscal year ending January 2, 2020 and ending on the last day of the Company's fiscal year ending December 31, 2022. F3 · derivative.expiration_date: Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Common Stock after the determination of the achievement of the performance goals during the three-year performance period beginning on the first day of the Company's fiscal year ending January 2, 2020 and ending on the last day of the Company's fiscal year ending December 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.